On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiologyDavid B. Chou, Donald E. Ingber, Viktoras Frismantas et al.|Nature Biomedical Engineering|2020Cited by 296
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E. Dandoy, Sonata Jodele, Michelle Long Schoettler et al.|Blood Advances|2020Cited by 92
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic SyndromesChristine Duncan, Mohamed L. Sorror, Navneet S. Majhail et al.|Biology of Blood and Marrow Transplantation|2014Cited by 64
TGF-β signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond syndromeCailin E. Joyce, Carl D. Novina, Assieh Saadatpour et al.|Journal of Clinical Investigation|2019Cited by 34